Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.

Thalidomide, which inhibits angiogenesis in certain tumor types, reduced extravasation of a macromolecular contrast medium (MMCM) in a human breast cancer model as assayed by MMCM-enhanced dynamic magnetic resonance imaging (MRI) and fluorescence microscopy in the same tumors. After a 1-week, three-...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Radiology Vol. 19; no. 1; pp. 121 - 132
Autores principales:	Cyran CC, Sennino B, Chaopathomkul B, Fu Y, Rogut VS, Shames DM, Wendland MF, McDonald DM, Brasch RC, Cyran, Clemens C, Sennino, Barbara, Chaopathomkul, Bundit, Fu, Yanjun, Rogut, Victor S, Shames, David M, Wendland, Michael F, McDonald, Donald M, Brasch, Robert C
Formato:	research Journal Article
Publicado:	Springer Nature Jan2009
Acceso en línea:	Ver este registro en EBSCOhost